Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Exits Eight Manufacturing Sites And Slices Jobs In Six More

This article was originally published in The Tan Sheet

Executive Summary

Pfizer will stop production of consumer health care products in Virginia and New York while expanding its consumer product operations in Puerto Rico in a realignment of its manufacturing network
Advertisement

Related Content

Pfizer Turns To Insider Ian Read To Lead Into Post-Lipitor Era
Pfizer Turns To Insider Ian Read To Lead Into Post-Lipitor Era
Pfizer Turns To Insider Ian Read To Lead Into Post-Lipitor Era
Capsugel Could Land In Private Equity Crosshairs If Pfizer Divests
Capsugel Could Land In Private Equity Crosshairs If Pfizer Divests
Capsugel Could Land In Private Equity Crosshairs If Pfizer Divests
Capsugel Could Land In Private Equity If Pfizer Divests
Pfizer expands Singapore nutrition plant
Pfizer Plans To Give Diversified Businesses Time To Grow
Pfizer Plans To Give Diversified Businesses Time To Grow

Topics

Advertisement
UsernamePublicRestriction

Register

PS104144

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel